• New tools to improve care of older people

    8 February 2019

    Digital checks that can detect dementia and prevent falls in older people, and save lives through diagnosis of sepsis, are among a range of tools being made available in hospitals across the country.

    One in eight hospital patients are affected by delirium, which can make people unsteady on their feet, increases the risk of developing dementia and can result in longer hospital stays or admission to a care home.

    These problems can be avoided through timely and effective care, with a scheme in Salford increasing the number of patients correctly diagnosed with delirium by 34%, through the introduction of screening for all over-65s who are admitted to hospital.

    Read More
  • Diabetes Prevention Week 2019 toolkits now available

    8 February 2019

    Diabetes Prevention Week, 1 to 7 April 2019, aims to raise awareness of Type 2 diabetes, complications associated with the condition, at-risk groups and prevention strategies. Local NHS organisations can order a toolkit for running events and local campaigns.

    Read More
  • When your pharmacy can give you a headache: a prescription for dispensing practices

    7 February 2019

    As with any change, the drive to deliver primary care at scale carries with it the risk of unintended consequences.

    For a dispensing practice looking to merge or to move to shiny new premises, the loss of a valuable income stream from dispensing can be one.

    PCC primary care adviser Charlotte Goodson cautions that the regulations in this area are particularly opaque and complex and dispensing practices need to take stock when planning changes.

    Read More
  • NICE recommends another revolutionary CAR T-cell therapy for adults with lymphoma

    5 February 2019

    Adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) will be able to access another revolutionary chimeric antigen receptor T-Cell (CAR T-cell) therapy through the cancer drugs fund.

    Tisagenlecleucel, also known as Kymriah and made by Novartis, is recommended for adults with relapsed or refractory DLBCL. It will be offered to people whose disease has not responded or those whose disease has relapsed after treatment with two or more courses of chemotherapy.

    Lymphomas are cancers of the lymphatic system which is part of the immune system. There were 11,690 new cases of non-Hodgkin lymphoma (NHL) in England in 2015 with 4,688 of these being diffuse large B-cell lymphoma.

    Read More
  • Update on vaccines for 2019/20 seasonal flu programme

    5 February 2019

    NHS England has issued further information on recommended seasonal flu vaccines for 2019/20. It confirms which vaccines should be ordered by providers of the seasonal flu vaccination programme, including which are eligible for reimbursement.

    Read More

Pages